Kristen N. Ganjoo, MD

Stanford Comprehensive Cancer Center
Palo Alto, California, United States

Disclosure information not submitted.

Presentation(s):

• Paper 84 - PLANNED ANALYSIS OF THE PIVOTAL IGNYTE-ESO TRIAL OF LETE-CEL IN PATIENTS WITH SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA.

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST

• Paper 87 - CELLSARCTX: A SINGLE-CELL TRANSCRIPTOMICS ATLAS OF ADOPTIVE CELLULAR THERAPY TARGETS IN SOFT TISSUE SARCOMAS

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST

• Paper 106 - SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED PRIOR ANTI-COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 STUDY

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST